All Stories

  1. ABPA relapse after discontinuation of omalizumab

    Article • September 2020, European Respiratory Society (ERS)

    Caterina Bucca

  2. Effect of ABPA treatment in severe asthma patients with acute and relapsed disease

    Article • September 2020, European Respiratory Society (ERS)

    Caterina Bucca

  3. Aspergillus sensitization and aspergillus-associated diseases in a sample of patients with severe asthma

    Article • September 2019, European Respiratory Society (ERS)

    Caterina Bucca

  4. Eosinophils Target Therapy for Severe Asthma: Critical Points

    Article • BioMed Research International, October 2018, Hindawi Publishing Corporation

    Enrico Heffler, Stefania Nicola, Caterina Bucca

  5. Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS

    Article • Clinical & Experimental Allergy, August 2018, Wiley

    Professor Joao A Fonseca, Sinthia Bosnic-Anticevich, Caterina Bucca